{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:08:13Z","timestamp":1765544893112,"version":"build-2065373602"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Peripheral arterial disease (PAD) causes leg muscle damage due to inadequate perfusion and increases cardiovascular events and mortality 2- to 3-fold. It is unclear if PAD is a biomarker for high-risk cardiovascular disease or if skeletal muscle injury harms arterial health. The objective of this work is to test if serum myoglobin levels (myoglobinemia) are a marker of PAD, and if so, whether myoglobin impairs vascular health.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY DESIGN:<\/jats:title>\n            <jats:p>Patient blood samples were collected from PAD and control (no PAD) patients and interrogated for myoglobin concentrations and nitric oxide bioavailability. Patient mortality over time was captured from the medical record. Myoglobin activity was tested on endothelial cells and arterial function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Myoglobin is a biomarker for symptomatic PAD and was inversely related to nitric oxide bioavailability; 200\u2009ng\/mL myoglobin in vitro increased endothelial cell permeability in vitro and decreased nitrate bioavailability. Ex vivo, 100\u2009ng\/mL myoglobin increased vascular tone in naive murine aortas approximately 1.5 times, impairing absolute vessel relaxation. In vivo, we demonstrated that myoglobinemia caused impaired flow-mediated dilation in a porcine model. Patients presenting with myoglobin levels of 100\u2009ng\/mL or greater had significantly more deaths than those with myoglobin levels of less than 100\u2009ng\/mL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Using a combination of patient data, in vitro, ex vivo, and in vivo testing, we found that myoglobin is a biomarker for symptomatic PAD and a potent regulator of arterial health that can increase vascular tone, increase vascular permeability, and cause endothelial dysfunction, all of which may contribute to the vulnerability of PAD patients to cardiovascular events and death.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/xcs.0000000000000554","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T11:02:08Z","timestamp":1674126128000},"page":"588-598","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Myoglobinemia, Peripheral Arterial Disease, and Patient Mortality"],"prefix":"10.1097","volume":"236","author":[{"given":"Ottis","family":"Scrivner","sequence":"first","affiliation":[{"name":"From the Emory University Department of Surgery, Atlanta, GA (Scrivner, Hoffmann, Li, Jordan, Brewster)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Baylor University, Department of Biology, Waco, TX (Fletcher, Wilkinson, Koutakis)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carson","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"From the Emory University Department of Surgery, Atlanta, GA (Scrivner, Hoffmann, Li, Jordan, Brewster)"},{"name":"Atlanta VA Medical Center, Atlanta, GA (Hoffmann, Brewster)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Li","sequence":"additional","affiliation":[{"name":"From the Emory University Department of Surgery, Atlanta, GA (Scrivner, Hoffmann, Li, Jordan, Brewster)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Baylor University, Department of Biology, Waco, TX (Fletcher, Wilkinson, Koutakis)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Miserlis","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center San Antonio, Department of Surgery, San Antonio, TX (Miserlis)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S","family":"Smith","sequence":"additional","affiliation":[{"name":"Baylor Scott and White Medical Center, Department of Surgery, Temple, TX (Smith, Bohannon)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T","family":"Bohannon","sequence":"additional","affiliation":[{"name":"Baylor Scott and White Medical Center, Department of Surgery, Temple, TX (Smith, Bohannon)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Sutliff","sequence":"additional","affiliation":[{"name":"National Institutes of Health, National Heart, Lung, and Blood Institute, Lung Biology and Disease Branch, Atlanta, GA (Sutliff)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D","family":"Jordan","sequence":"additional","affiliation":[{"name":"From the Emory University Department of Surgery, Atlanta, GA (Scrivner, Hoffmann, Li, Jordan, Brewster)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Koutakis","sequence":"additional","affiliation":[{"name":"Baylor University, Department of Biology, Waco, TX (Fletcher, Wilkinson, Koutakis)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke P","family":"Brewster","sequence":"additional","affiliation":[{"name":"From the Emory University Department of Surgery, Atlanta, GA (Scrivner, Hoffmann, Li, Jordan, Brewster)"},{"name":"Atlanta VA Medical Center, Atlanta, GA (Hoffmann, Brewster)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"R1-20250821","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"key":"R2-20250821","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease.","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"key":"R3-20250821","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archinte.163.8.884","article-title":"Critical issues in peripheral arterial disease detection and management: a call to action.","volume":"163","author":"Belch","year":"2003","journal-title":"Arch Intern Med"},{"key":"R4-20250821","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.pu.16.050195.001551","article-title":"The status of health assessment 1994.","volume":"16","author":"Ware","year":"1995","journal-title":"Annu Rev Public Health"},{"key":"R5-20250821","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association.","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"R6-20250821","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"R7-20250821","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jacc.2008.07.060","article-title":"Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality.","volume":"52","author":"Criqui","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R8-20250821","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2006.03.067","article-title":"The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials.","volume":"48","author":"Saw","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R9-20250821","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1358863X15623629","article-title":"The association between ischemic and jeopardized myocardia and all-cause mortality in patients with peripheral artery disease.","volume":"21","author":"Hammad","year":"2016","journal-title":"Vasc Med"},{"key":"R10-20250821","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0741-5214(03)00124-1","article-title":"Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden.","volume":"38","author":"Brevetti","year":"2003","journal-title":"J Vasc Surg"},{"key":"R11-20250821","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2261-5-14","article-title":"The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database.","volume":"5","author":"Caro","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"R12-20250821","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejvs.2018.01.019","article-title":"Ten year mortality in different peripheral arterial disease stages: a population based observational study on outcome.","volume":"55","author":"Sartipy","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R13-20250821","first-page":"347","article-title":"Trends in peripheral vascular procedures in the Veterans Health Administration, 1989-1998.","volume":"38","author":"Mayfield","year":"2001","journal-title":"J Rehabil Res Dev"},{"key":"R14-20250821","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.apmr.2011.03.029","article-title":"Factors influencing receipt of outpatient rehabilitation services among veterans following lower extremity amputation.","volume":"92","author":"Zhou","year":"2011","journal-title":"Arch Phys Med Rehabil"},{"key":"R15-20250821","first-page":"e29","article-title":"Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association.","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"R16-20250821","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jvs.2014.02.013","article-title":"Peripheral arterial disease, gender, and depression in the Heart and Soul Study.","volume":"60","author":"Grenon","year":"2014","journal-title":"J Vasc Surg"},{"key":"R17-20250821","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jvs.2013.10.084","article-title":"Walking disability in patients with peripheral artery disease is associated with arterial endothelial function.","volume":"59","author":"Grenon","year":"2014","journal-title":"J Vasc Surg"},{"key":"R18-20250821","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2018.08.002","article-title":"Pathology of peripheral artery disease in patients with critical limb ischemia.","volume":"72","author":"Narula","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R19-20250821","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/ATVBAHA.121.316252","article-title":"Medial arterial calcification: a significant and independent contributor of peripheral artery disease.","volume":"42","author":"St Hilaire","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R20-20250821","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"R21-20250821","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1182\/blood-2008-01-115261","article-title":"The functional nitrite reductase activity of the heme-globins.","volume":"112","author":"Gladwin","year":"2008","journal-title":"Blood"},{"key":"R22-20250821","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/CIRCULATIONAHA.116.024752","article-title":"How red blood cells process nitric oxide: evidence for the nitrite hypothesis.","volume":"135","author":"Gladwin","year":"2017","journal-title":"Circulation"},{"key":"R23-20250821","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nm0503-496","volume":"9","author":"Gladwin","year":"2003","journal-title":"Nat Med"},{"key":"R24-20250821","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/antiox9070590","article-title":"The nitric oxide system in peripheral artery disease: connection with oxidative stress and biopterins.","volume":"9","author":"Ismaeel","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"R25-20250821","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1152\/ajpendo.00134.2005","article-title":"Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats.","volume":"290","author":"Thule","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R26-20250821","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/bja\/79.1.84","article-title":"Role of endothelium in the modulation of isoflurane-induced vasodilatation in rat thoracic aorta.","volume":"79","author":"Kirstetter","year":"1997","journal-title":"Br J Anaesth"},{"key":"R27-20250821","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jvs.2016.07.127","article-title":"An endovascular model of ischemic myopathy from peripheral arterial disease.","volume":"66","author":"Long","year":"2017","journal-title":"J Vasc Surg"},{"key":"R28-20250821","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17461391.2017.1330899","article-title":"Validity and reliability of the Moxy oxygen monitor during incremental cycling exercise.","volume":"17","author":"Crum","year":"2017","journal-title":"Eur J Sport Sci"},{"key":"R29-20250821","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00421-022-04944-0","article-title":"Aging alters gastrocnemius muscle hemoglobin oxygen saturation (StO2) characteristics in healthy individuals.","volume":"122","author":"Holmes","year":"2022","journal-title":"Eur J Appl Physiol"},{"key":"R30-20250821","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.3390\/ijms22073601","article-title":"The role of circulating biomarkers in peripheral arterial disease.","volume":"22","author":"Saenz-Pipaon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R31-20250821","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease.","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R32-20250821","doi-asserted-by":"crossref","first-page":"17539447221096940","DOI":"10.1177\/17539447221096940","article-title":"MicroRNAs in peripheral artery disease: potential biomarkers and pathophysiological mechanisms.","volume":"16","author":"Ring","year":"2022","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"R33-20250821","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1021\/acs.biochem.5b00807","article-title":"Interactions of haptoglobin with monomeric globin species: insights from molecular modeling and native electrospray ionization mass spectrometry.","volume":"55","author":"Fatunmbi","year":"2016","journal-title":"Biochemistry"},{"key":"R34-20250821","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1038\/s41467-022-34154-3","article-title":"Endothelial alpha globin is a nitrite reductase.","volume":"13","author":"Keller","year":"2022","journal-title":"Nat Commun"},{"issue":"Pt 2","key":"R35-20250821","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/000456329703400212","article-title":"Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels.","volume":"34","author":"Giovannoni","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"R36-20250821","doi-asserted-by":"crossref","first-page":"e002938","DOI":"10.1161\/JAHA.115.002938","article-title":"Critical limb ischemia: current trends and future directions.","volume":"5","author":"Teraa","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R37-20250821","doi-asserted-by":"crossref","first-page":"100371","DOI":"10.1016\/j.ajpc.2022.100371","article-title":"There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: a review of current practice and recommendations for improved effectiveness.","volume":"12","author":"Makover","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"R38-20250821","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jamcollsurg.2007.12.033","article-title":"Do current outcomes justify more liberal use of revascularization for vasculogenic claudication? A single center experience of 1,000 consecutively treated limbs.","volume":"206","author":"Taylor","year":"2008","journal-title":"J Am Coll Surg"}],"container-title":["Journal of the American College of Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/XCS.0000000000000554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:09:42Z","timestamp":1755806982000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/XCS.0000000000000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/xcs.0000000000000554","relation":{},"ISSN":["1072-7515"],"issn-type":[{"type":"print","value":"1072-7515"}],"subject":[],"published":{"date-parts":[[2023,1,20]]}}}